Met Life Investment Management, LLC Chroma Dex Corp. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 26,559 shares of CDXC stock, worth $155,901. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,559
Previous 18,114
46.62%
Holding current value
$155,901
Previous $66,000
113.64%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CDXC
# of Institutions
122Shares Held
20.3MCall Options Held
149KPut Options Held
26.3K-
Vanguard Group Inc Valley Forge, PA3.39MShares$19.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$18.3 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$15.2 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.61 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.78 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $401M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...